Monitoring RAS Phenotypic Changes Based on ctDNA to Predict the Efficacy of Cetuximab in Metastatic Colorectal Cancer
Ontology highlight
ABSTRACT: Interventions: Gold Standard:Clinical outcome;Index test:RAS phenotypic changes in ctDNA
Primary outcome(s): RAS gene phenotype;SEN, SPE, ACC, AUC of ROC
Study Design: Sequential
DISEASE(S): Colorectal Cancer
PROVIDER: 2687923 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA